Clinical Trial Update: Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma [Phase 2]

View source ↗

Summary

Phase II trial update for intratumoral IL12 plasmid electroporation in cutaneous T cell lymphomas, including mycosis fungoides; study terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Cell Lymphomas
• Mycosis Fungoides

Drugs mentioned

• IL12 plasmid electroporation (interleukin-12 plasmid electroporation)

Snippet

Sponsor: OncoSec Medical Incorporated | Conditions: Cutaneous T Cell Lymphomas (CTCL), Mycosis Fungoides (MF) | Phase 2 | Status: TERMINATED | Results posted: 2018-01-03